<SEC-DOCUMENT>0001140361-25-046189.txt : 20251219
<SEC-HEADER>0001140361-25-046189.hdr.sgml : 20251219
<ACCEPTANCE-DATETIME>20251219160542
ACCESSION NUMBER:		0001140361-25-046189
CONFORMED SUBMISSION TYPE:	15-12G
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20251219
DATE AS OF CHANGE:		20251219
EFFECTIVENESS DATE:		20251219

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Akero Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001744659
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		15-12G
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38944
		FILM NUMBER:		251587523

	BUSINESS ADDRESS:	
		STREET 1:		601 GATEWAY BOULEVARD, SUITE 350
		CITY:			SOUTH SAN FRANCISCO
		STATE:			CA
		ZIP:			94080
		BUSINESS PHONE:		650-487-6488

	MAIL ADDRESS:	
		STREET 1:		601 GATEWAY BOULEVARD, SUITE 350
		CITY:			SOUTH SAN FRANCISCO
		STATE:			CA
		ZIP:			94080
</SEC-HEADER>
<DOCUMENT>
<TYPE>15-12G
<SEQUENCE>1
<FILENAME>ef20061504_15-12g.htm
<DESCRIPTION>15-12G
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc.
         Document created using Broadridge PROfile 25.10.1.5333
         Copyright 1995 - 2025 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">


  <div>
    <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;">
    <div>
      <div>
        <div style="text-align: center; font-size: 18pt; font-weight: bold;"><font style="font-size: 10pt;"> </font><font style="font-size: 14pt;">UNITED STATES</font></div>
      </div>
      <div style="text-align: center; font-size: 14pt; font-weight: bold;">SECURITIES AND EXCHANGE COMMISSION</div>
      <div style="text-align: center; font-size: 12pt; font-weight: bold;">Washington, D.C. 20549</div>
      <div> <br>
        </div>
      <div>
        <hr align="center" noshade="noshade" style="height: 2px; width: 100%; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
      <div style="text-align: center; font-weight: bold;"> <br>
      </div>
      <div style="text-align: center; font-size: 18pt; font-weight: bold;">FORM 15</div>
      <div style="text-align: center; font-weight: bold;"> <br>
      </div>
      <div>
        <hr align="center" noshade="noshade" style="height: 2px; width: 100%; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
      <div>&#160;</div>
      <div style="text-align: center; font-weight: bold;">CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION</div>
      <div style="text-align: center; font-weight: bold;">UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934</div>
      <div style="text-align: center; font-weight: bold;">OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d)</div>
      <div style="text-align: center; font-weight: bold;">OF THE SECURITIES EXCHANGE ACT OF 1934</div>
      <div>&#160;</div>
      <div style="text-align: center; font-weight: bold;">Commission File No. 001-38944</div>
      <div> <br>
        </div>
      <div>
        <hr align="center" noshade="noshade" style="height: 2px; width: 100%; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
      <div style="text-align: center; font-weight: bold;"> <br>
      </div>
      <div style="text-align: center; font-size: 24pt; font-weight: bold;">Akero Therapeutics, Inc.</div>
      <div style="text-align: center; font-weight: bold;">(Exact name of registrant as specified in its charter)</div>
      <div style="text-align: center; font-weight: bold;"> <br>
      </div>
      <div>
        <hr align="center" noshade="noshade" style="height: 2px; width: 100%; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
      <div>&#160;</div>
      <div style="text-align: center; font-weight: bold;">601 Gateway Boulevard, Suite 350</div>
      <div style="text-align: center; font-weight: bold;">South San Francisco, CA 94080</div>
      <div style="text-align: center; font-weight: bold;">(650) 487-6488</div>
      <div style="text-align: center; font-weight: bold;">(Address, including zip code, and telephone number, including area code, of registrant&#8217;s principal executive offices)</div>
      <div>&#160;</div>
      <div style="text-align: center; font-weight: bold;">Common Stock, par value $0.001 per share</div>
      <div style="text-align: center; font-weight: bold;">(Title of each class of securities covered by this Form)</div>
      <div>&#160;</div>
      <div style="text-align: center; font-weight: bold;">None</div>
      <div style="text-align: center; font-weight: bold;">(Titles of all other classes of securities for which a duty to file reports under Section 13(a) or 15(d) remains)</div>
      <div style="text-align: center; font-weight: bold;"> <br>
      </div>
      <div>
        <hr align="center" noshade="noshade" style="height: 2px; width: 100%; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
      <div>&#160;</div>
      <div style="text-indent: 24.5pt;">Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:</div>
      <div> <br>
        </div>
      <table cellspacing="0" cellpadding="0" id="z7130c1bfc7494815aa174a7ae7b9d73e" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td style="width: 89.98%; vertical-align: top;">
              <div style="text-indent: -10pt; margin-left: 10pt; color: rgb(0, 0, 0);">Rule 12g-4(a)(1)</div>
            </td>
            <td style="width: 0.33%; vertical-align: bottom;">&#160;</td>
            <td nowrap="nowrap" style="width: 9.69%; vertical-align: bottom;">
              <div style="text-align: right; color: rgb(0, 0, 0);">&#9746;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 89.98%; vertical-align: top;">
              <div style="text-indent: -10pt; margin-left: 10pt; color: rgb(0, 0, 0);">Rule 12g-4(a)(2)</div>
            </td>
            <td style="width: 0.33%; vertical-align: bottom;">&#160;</td>
            <td nowrap="nowrap" style="width: 9.69%; vertical-align: bottom;">
              <div style="text-align: right; color: rgb(0, 0, 0);">&#9744;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 89.98%; vertical-align: top;">
              <div style="text-indent: -10pt; margin-left: 10pt; color: rgb(0, 0, 0);">Rule 12h-3(b)(1)(i)</div>
            </td>
            <td style="width: 0.33%; vertical-align: bottom;">&#160;</td>
            <td nowrap="nowrap" style="width: 9.69%; vertical-align: bottom;">
              <div style="text-align: right; color: rgb(0, 0, 0);">&#9746;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 89.98%; vertical-align: top;">
              <div style="text-indent: -10pt; margin-left: 10pt; color: rgb(0, 0, 0);">Rule 12h-3(b)(1)(ii)</div>
            </td>
            <td style="width: 0.33%; vertical-align: bottom;">&#160;</td>
            <td nowrap="nowrap" style="width: 9.69%; vertical-align: bottom;">
              <div style="text-align: right; color: rgb(0, 0, 0);">&#9744;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 89.98%; vertical-align: top;">
              <div style="text-indent: -10pt; margin-left: 10pt; color: rgb(0, 0, 0);">Rule 15d-6</div>
            </td>
            <td style="width: 0.33%; vertical-align: bottom;">&#160;</td>
            <td style="width: 9.69%; vertical-align: bottom;">
              <div style="text-align: right; color: rgb(0, 0, 0);">&#9744;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 89.98%; vertical-align: top;">
              <div style="text-indent: -10pt; margin-left: 10pt; color: rgb(0, 0, 0);">Rule 15d-22(b)</div>
            </td>
            <td style="width: 0.33%; vertical-align: bottom;">&#160;</td>
            <td nowrap="nowrap" style="width: 9.69%; vertical-align: bottom;">
              <div style="text-align: right; color: rgb(0, 0, 0);">&#9744;</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div>
        <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"></div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-indent: 24.5pt;">Approximate number of holders of record as of the certification or notice date: One.</div>
      <div>&#160;</div>
      <div style="text-indent: 24.5pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, Akero Therapeutics, Inc. has caused this certification/notice to be signed on
        its behalf by the undersigned duly authorized person.</div>
      <div> <br>
        </div>
      <table cellspacing="0" cellpadding="0" border="0" id="z26056818e5c14f1cb6c6e4f675214294" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td style="width: 4.99%; vertical-align: bottom;">&#160;</td>
            <td style="width: 44.95%; vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;" colspan="2">
              <div style="color: rgb(0, 0, 0); font-weight: bold;">Akero Therapeutics, Inc.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 4.99%; vertical-align: middle;">&#160;</td>
            <td style="vertical-align: middle;">&#160;</td>
            <td style="vertical-align: middle;">&#160;</td>
            <td style="vertical-align: middle;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 4.99%; vertical-align: bottom;">
              <div style="color: rgb(0, 0, 0);">Date:</div>
            </td>
            <td style="width: 44.95%; vertical-align: bottom;">
              <div style="color: rgb(0, 0, 0);">December 19, 2025</div>
            </td>
            <td style="width: 4.99%; vertical-align: bottom;">
              <div style="color: rgb(0, 0, 0);">By:</div>
            </td>
            <td style="width: 44.95%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
              <div>
                <div style="color: rgb(0, 0, 0);">&#160;/s/ Jonathan Young</div>
              </div>
            </td>
          </tr>
          <tr>
            <td style="width: 4.99%; vertical-align: bottom;">&#160;</td>
            <td style="width: 44.95%; vertical-align: bottom;">&#160;</td>
            <td style="width: 4.99%; vertical-align: bottom;">&#160;</td>
            <td style="width: 44.95%; vertical-align: bottom;">
              <div style="color: rgb(0, 0, 0);">Jonathan Young, J.D., Ph.D.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 4.99%; vertical-align: bottom;">&#160;</td>
            <td style="width: 44.95%; vertical-align: bottom;">&#160;</td>
            <td style="width: 4.99%; vertical-align: bottom;">&#160;</td>
            <td style="width: 44.95%; vertical-align: bottom;">
              <div style="color: rgb(0, 0, 0);">Assistant Treasurer</div>
            </td>
          </tr>

      </table>
      <div> <br>
        </div>
      <div><br>
      </div>
    </div>
    <div>
      <hr align="center" noshade="noshade" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"> </div>
  </div>


</body>
</html>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
